Health Canada has authorized two new drugs under the brand name Paxlovid, to treat adults with mild to moderate COVID-19 who are at high risk of progressing to serious disease.
Source:
https://www.canada.ca/en/health-canada/news/2022/01/health-canada-authorizes-paxlovidtm-for-patients-with-mild-to-moderate-covid-19-at-high-risk-of-developing-serious-disease.html

Produced by Saveta Cartwright.